Ou Ou

Dr. Ou Ou

Eye Institute of Xiamen University and affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
XZXiaobo Zhang
Xiaobo Zhang
VMVimalin Jeyalatha Mani
Vimalin Jeyalatha Mani
YQYangluowa Qu
Yangluowa Qu
XHXin He
Xin He
Ou OuOu Ou
Ou Ou
WLWei Li
Wei Li
Dry eye can damage the ocular surface and result in mild corneal epithelial defect to blinding corneal pannus formation and squamous metaplasia. Significant progress in the treatment of dry eye has been made in the last two decades; progressing from lubricating and hydrating the ocular surface with artificial tear to stimulating tear secretion; anti-inflammation and immune regulation. With the increase in knowledge regarding the pathophysiology of dry eye, we propose in this review the concept of ocular surface microenvironment. Various components of the microenvironment contribute to the homeostasis of ocular surface. Compromise in one or more components can result in homeostasis disruption of ocular surface leading to dry eye disease. Complete evaluation of the microenvironment component changes in dry eye patients will not only lead to appropriate diagnosis, but also guide in timely and effective clinical management. Successful treatment of dry eye should be aimed to restore the homeostasis of the ocular surface microenvironment.

29 May 2020 in Advanced Science
Verified
Journal Article
Open access
PDF file
CCChengchao Chu
Chengchao Chu
JYJingwen Yu
Jingwen Yu
EREn Ren
En Ren
Ou OuOu Ou
Ou Ou
YZYunming Zhang
Yunming Zhang
Gang LiuGang Liu
Gang Liu
Corneal neovascularization (CNV) is one of the main factors that induce blindness worldwide. However, current medical treatments cannot achieve non‐invasive and safe inhibition of CNV. A noninvasive photoacoustic imaging (PAI)‐guided method is purposed for the regression of CNV. PAI can monitor the oxygen saturation of cornea blood vessels through the endogenous contrast of hemoglobin and trace administrated drugs by themselves as exogenous contrast agents. An indocyanine green (ICG)‐based nanocomposite (R‐s‐ICG) is prepared for CNV treatment via eye drops and subconjunctival injections. It is demonstrated that R‐s‐ICG can enrich corneal tissues and pathological blood vessels rapidly with minor residua in normal eyeball tissues. Anti‐CNV treatment‐driven changes in the blood vessels are assessed by real‐time multimodal PAI in vivo, and then a safe laser irradiation strategy through the canthus is developed for phototherapy and gene therapy synergistic treatment. The treatment leads to the efficient inhibition of CNV with faint damages to normal tissues.

1 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JCJingyao Chen
Jingyao Chen
ZLZhiyuan Li
Zhiyuan Li
LZLiying Zhang
Liying Zhang
Ou OuOu Ou
Ou Ou
YWYanzi Wang
Yanzi Wang
WLWei Li
Wei Li
Descemet’s membrane (DM) helps maintain phenotype and function of corneal endothelial cells under physiological conditions, while little is known about the function of DM in corneal endothelial wound healing process. In the current study, we performed in vivo rabbit corneal endothelial cell (CEC) injury via CEC scraping, in which DM remained intact after CECs removal, or via DM stripping, in which DM was removed together with CECs. We found rabbit corneas in the CEC scraping group healed with transparency restoration, while there was posterior fibrosis tissue formation in the corneas after DM stripping on day 14. Following CEC scraping on day 3, cells that had migrated toward the central cornea underwent a transient fibrotic endothelial-mesenchymal transition (EMT) which was reversed back to an endothelial phenotype on day 14. However, in the corneas injured via DM stripping, most of the cells in the posterior fibrosis tissue did not originate from the corneal endothelium, and they maintained fibroblastic phenotype on day 14. We concluded that corneal endothelial wound healing in rabbits has different outcomes depending upon the presence or absence of Descemet’s membrane. Descemet’s membrane supports corneal endothelial cell regeneration in rabbits after endothelial injury.

15 February 2016 in Scientific Reports
Verified
Journal Article
Open access
LZLiying Zhang
Liying Zhang
DZDulei Zou
Dulei Zou
SLSanming Li
Sanming Li
JWJunqi Wang
Junqi Wang
YQYangluowa Qu
Yangluowa Qu
WLWei Li
Wei Li
Amniotic membranes (AMs) are widely used as a corneal epithelial tissue carrier in reconstruction surgery. However, the engineered tissue transparency is low due to the translucent thick underlying AM stroma. To overcome this drawback, we developed an ultra-thin AM (UAM) by using collagenase IV to strip away from the epithelial denuded AM (DAM) some of the stroma. By thinning the stroma to about 30 μm, its moist and dry forms were rendered acellular, optically clear and its collagen framework became compacted and inerratic. Engineered rabbit corneal epithelial cell (RCEC) sheets generated through expansion of limbal epithelial cells on UAM were more transparent and thicker than those expanded on DAM. Moreover, ΔNp63 and ABCG2 gene expression was greater in tissue engineered cell sheets expanded on UAM than on DAM. Furthermore, 2 weeks after surgery, the cornea grafted with UAM based cell sheets showed higher transparency and more stratified epithelium than the cornea grafted with DAM based cell sheets. Taken together, tissue engineered corneal epithelium generated on UAM has a preferable outcome because the transplanted tissue is more transparent and better resembles the phenotype of the native tissue than that obtained by using DAM for this procedure. UAM preserves compact layer of the amniotic membrane and maybe an ideal substrate for corneal epithelial tissue engineering.

1 October 2017 in Experimental Eye Research
Verified
Journal Article
Closed access
MJM. Vimalin Jeyalatha
M. Vimalin Jeyalatha
YQYangluowa Qu
Yangluowa Qu
ZLZhen Liu
Zhen Liu
Ou OuOu Ou
Ou Ou
XHXin He
Xin He
WLWei Li
Wei Li

1 October 2020 in The Ocular Surface
Verified
Journal Article
Closed access
JHJia He
Jia He
Ou OuOu Ou
Ou Ou
JRJun Ren
Jun Ren
HSHuimin Sun
Huimin Sun
XHXin He
Xin He
WLWei Li
Wei Li